Literature DB >> 34978577

[Stopping antidepressants: withdrawal symptoms and rebound effects : Review and practical recommendations].

T Bschor1,2, U Bonnet3,4,5, M Pitzer3,6, C Baethge3,7, K Lieb3,8, H-J Gertz3,9, B Müller-Oerlinghausen3.   

Abstract

Stopping antidepressants can cause withdrawal (discontinuation) symptoms, the return of the original illness, and rebound. The latter means that the disease will return stronger, faster, or with greater likelihood than if it had not been treated with medication. The Psychiatry Working Group of the Drug Commission of the German Medical Association (AkdÄ) presents the scientific findings and provides practical recommendations for action. Withdrawal symptoms are multiform; unspecific physical symptoms are predominant. Distinguishing them from the recurrence of depressive symptoms can be difficult. Most of them are mild and self-limiting. There is insufficient evidence on the extent and frequency of rebound depression. The rebound risk implies that when establishing the medication, the short-term benefit must be weighed against the possible long-term risk of chronic depression or the possible need for long-term medication. Patients should be informed about the risk of withdrawal both as early as the joint decision-making process about treatment initiation and regularly during the course of treatment. Withdrawal should take place gradually, except in emergency situations, whereby small steps should be taken, especially in the low-dose range.
© 2021. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Antidepressants/discontinuation; Antidepressants/withdrawal; Chronic depression; Rebound depression; Tapering of antidepressants

Mesh:

Substances:

Year:  2022        PMID: 34978577     DOI: 10.1007/s00115-021-01243-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  6 in total

Review 1.  Antidepressant Withdrawal and Rebound Phenomena.

Authors:  Jonathan Henssler; Andreas Heinz; Lasse Brandt; Tom Bschor
Journal:  Dtsch Arztebl Int       Date:  2019-05-17       Impact factor: 5.594

Review 2.  Chronic and treatment resistant depression: diagnosis and stepwise therapy.

Authors:  Tom Bschor; Michael Bauer; Mazda Adli
Journal:  Dtsch Arztebl Int       Date:  2014-11-07       Impact factor: 5.594

3.  Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.

Authors:  Ellen Van Leeuwen; Mieke L van Driel; Mark A Horowitz; Tony Kendrick; Maria Donald; An Im De Sutter; Lindsay Robertson; Thierry Christiaens
Journal:  Cochrane Database Syst Rev       Date:  2021-04-15

4.  Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum.

Authors:  Michael P Hengartner; Lukas Schulthess; Anders Sorensen; Adele Framer
Journal:  Ther Adv Psychopharmacol       Date:  2020-12-24

Review 5.  The relationship between dose and serotonin transporter occupancy of antidepressants-a systematic review.

Authors:  Anders Sørensen; Henricus G Ruhé; Klaus Munkholm
Journal:  Mol Psychiatry       Date:  2021-09-21       Impact factor: 15.992

6.  Outcome of antidepressant drug discontinuation with taperingstrips after 1-5 years.

Authors:  Peter C Groot; Jim van Os
Journal:  Ther Adv Psychopharmacol       Date:  2020-09-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.